I suppose there is the skepticism of some, in believing that the company can pull off a BA for a project of this magnitude, despite the incredibly positive results we’ve had to date. This includes massively de-risking the project in terms of ROI and reduction of costs/timelines for subsequent studies.
Nevermind that the company’s zinc portfolio goes beyond AB and we also have potential upside in Cobalt and lithium too...... all 3 sectors are hot.
Matt and the team’s track record speaks volumes.... those of us who have been here for a while can attest to that.
At $20M odd MC, the company is severely undervalued when you weigh up risk vs reward, or compare the company to it’s junior peers on the ASX.
I’m expecting a massive year for the company and holders.
Hopefully a BA isn’t far off and we can add some cracker lithium/Cobalt results to the mix.
Cheyne.
MCT Price at posting:
4.4¢ Sentiment: Buy Disclosure: Held
